Fennec Pharmaceuticals share price logo

Fennec Pharmaceuticals

NASDAQ: FENC

Small Cap

$11.30

-0.35

(-3.00%)

as on

Fennec Pharmaceuticals Stock Performance

as on September 11, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.27
    $11.72
    downward going graph

    0.27%

    Downside

    3.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.65
    $13.25
    downward going graph

    50.00%

    Downside

    17.26%

    Upside

    downward going graph

Fennec Pharmaceuticals share price movements today

Previous Close
$11.65
Open
$11.52
Volume
245.4K
Market Cap
$436.6M
Day's Low - High
$11.27 - $11.72
52 Week Low - High
$5.65 - $13.25

Fennec Pharmaceuticals Historical Returns

1 Month Return
+ 6.49 %
3 Month Return
+ 33.91 %
1 Year Return
+ 29.3 %
3 Year Return
+ 42.07 %
5 Year Return
+ 42.25 %

Fennec Pharmaceuticals Stock Fundamentals & Key Indicators

Check Fennec Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$436.6M

EPS (TTM)

0.334

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

1.4678

EBITDA

-1.0M

Revenue (TTM)

59.2M

Profit Margin

-5.49%

Return On Equity TTM

-18.58%

Fennec Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fennec Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$436.6M42.25%NA-5.49%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for Fennec Pharmaceuticals Stock including INR - Dollar returns

The Fennec Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Fennec Pharmaceuticals investment value today

Current value as on today

₹1,35,923

Returns

₹35,923

(+35.92%)

Returns from Fennec Pharmaceuticals Stock

₹25,416 (+25.42%)

Dollar Impact

₹10,506 (+10.51%)

Analyst Recommendation on Fennec Pharmaceuticals Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Fennec Pharmaceuticals. Average target price of $17.67

Fennec Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Fennec Pharmaceuticals.

What analysts predicted

36.05%UPSIDE

Target Price

$17.67

Current Price

$11.3

Analyzed by

5 Analysts

Target

$17.67

Fennec Pharmaceuticals target price $17.67, a slight upside of 36.05% compared to current price of $11.3. According to 5 analysts rating.

Indian Investors' Interest in Fennec Pharmaceuticals Stock

Search interest for Fennec Pharmaceuticals Stock has increased by 382% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:382% versus previous 30 day period

Fennec Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
25
7
6
7
8
9
12
13
15
17
Gross Profit
24
6
5
7
8
8
11
12
14
17
Operating Income
13
-5
-5
0
0
-2
0
-2
0
1
EBITDA
14
-4
-4
0
0
-2
0
-4
0
1
Interest Expense
1
1
1
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
12
-5
-5
-1
-1
-3
0
-4
0
2
Income Tax Expense
0
0
-
0
-
-
-
0
-
0
Net Income
12
-5
-5
-1
-1
-3
0
-4
0
1
Net Profit Margin
50.59%
-76.47%
-82.23%
-25.05%
-13.31%
-32.66%
-5.12%
-34.75%
1.33%
11.04%

Fennec Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
1
21
47
44
Gross Profit
-
-
-
-
0
-
1
19
44
40
Operating Income
-2
-6
-10
-13
-17
-17
-22
-13
2
-6
EBITDA
0
0
0
-12
-18
-17
-22
-12
4
-7
Interest Expense
-
-
-
-
0
0
0
3
4
2
Depreciation
-
-
-
0
0
0
0
0
0
0
Income Before Tax
-2
-7
-9
-12
-18
-17
-23
-16
0
-9
Income Tax Expense
0
0
0
0
0
0
1
0
0
0
Net Income
-2
-7
-9
-12
-18
-17
-23
-16
0
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-10652.35%
-10203.53%
-1544.89%
-75.50%
-0.92%
-21.82%

Fennec Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-5
-1
-1
-3
0
-4
0
1
Operating Cash Flow
-8
-2
-1
-4
-3
1
-5
2
0
Investing Cash Flow
-
0
0
-
-
-
-
-
-
Financing Cash Flow
0
0
-12
0
0
1
20
1
1
Change in Cash
-8
-2
-13
-3
-3
3
14
3
1

Fennec Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-9
-12
-18
-17
-23
-16
0
-10
Operating Cash Flow
-3
-7
-9
-15
-14
-18
-17
26
-12
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
27
2
0
32
4
20
6
-13
22
Change in Cash
24
-5
-9
16
-9
2
-10
13
10

Mutual Funds that own Fennec Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Fennec Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.489594%
873030
Fidelity Salem Street Trust
0.909497%
318935
VANGUARD SCOTTSDALE FUNDS
0.388066%
136084
Bridgeway Funds, Inc.
0.236702%
83005
SCHWAB CAPITAL TRUST
0.181186%
63537

Global Institutional Holdings in Fennec Pharmaceuticals

Funds
Holdings
iShares
3.17%
Vanguard
2.89%
SPDR
0.3%
Xtrackers
0.07%
Global X
0.04%

Insights on Fennec Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, FENC has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, FENC stock has moved up by 27.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 438.1% return, outperforming this stock by 413.0%

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
OrganisationFennec Pharmaceuticals
Headquarters68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
IndustryBiotechnology
CEOMr. Jeffrey S. Hackman
E-voting on sharesClick here to vote

Key Management of Fennec Pharmaceuticals

Name

Title

Mr. Jeffrey S. Hackman

CEO & Director

Mr. Robert C. Andrade

Chief Financial Officer

Dr. Pierre S. Sayad M.S., Ph.D.

Chief Medical Officer

Mr. Terry Evans

Chief Commercial Officer

Ms. Christiana Cioffi M.B.A.

Chief Strategy Officer

Mr. Mark Gowland

Controller

Mr. Lei Fang

President of Pharstat Inc

FAQs

What is Fennec Pharmaceuticals share price today?

Fennec Pharmaceuticals share price today is $11.30 as on at the close of the market. Fennec Pharmaceuticals share today touched a day high of $11.72 and a low of $11.27.

What is the 52 week high and 52 week low for Fennec Pharmaceuticals share?

Fennec Pharmaceuticals share touched a 52 week high of $13.25 on and a 52 week low of $5.65 on . Fennec Pharmaceuticals stock price today i.e. is closed at $11.30,which is 14.72% down from its 52 week high and 100.00% up from its 52 week low.

What is Fennec Pharmaceuticals's market capitalisation today?

Fennec Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Fennec Pharmaceuticals Stock (FENC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Fennec Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fennec Pharmaceuticals Shares that will get you 0.1327 shares as per Fennec Pharmaceuticals share price of $11.30 per share as on September 11, 2026 at 8:46 am IST.

What is the minimum amount required to buy Fennec Pharmaceuticals Stock (FENC) from India?

Indian investors can start investing in Fennec Pharmaceuticals (FENC) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Fennec Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Fennec Pharmaceuticals share’s latest price of $11.30 as on September 11, 2026 at 8:46 am IST, you will get 0.8850 shares of Fennec Pharmaceuticals. Learn more about fractional shares .

What are the returns that Fennec Pharmaceuticals has given to Indian investors in the last 5 years?

Fennec Pharmaceuticals stock has given 42.25% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?